Back to search

Peptide record

TPDB05468

Antibacterial Anticancer Antiviral Toxicity standard
46 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB05468
Antibacterial Anticancer Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia AI4AVP dbAMP 3.0 DRAVP 2.0
standard
No
A 46-aa standard natural multi-activity (Antibacterial, Anticancer, Antiviral, and other sources) peptide sequence curated from AntiBP3, Peptipedia, AI4AVP, and other sources, with an available 3D structural model.
Sequence
QNQSANQFQKEISQINEVLTTTNTSLGKLQDDVNQNNQSLNTLQKE
Physicochemical Analysis
C216H356N66O83
RCHMPWY
Q
5205.59
4.28
3
5
11
-2
16.72
-1.191
74.13
Mammalian: 0.8 hour Yeast: 10 min E.coli: >10 hour
0
0.00
26
Residue Composition
number
1
A
0
R
8
N
2
D
0
C
3
E
9
Q
1
G
0
H
2
I
5
L
3
K
0
M
1
F
0
P
4
S
5
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 1 R: 0 N: 8 D: 2 C: 0 E: 3 Q: 9 G: 1 H: 0 I: 2 L: 5 K: 3 M: 0 F: 1 P: 0 S: 4 T: 5 W: 0 Y: 0 V: 2
Chemical Descriptors
46
C216H356N66O83
5205.59
4.28
-2
16.72
-1.191
Evidence Records 1 records
Evidence 1 Activity

Activity

0% Cytotoxicity
Toxicity
25 µM
Cytotoxic
0% Cytotoxicity | 25 | µM | target cell: Vero E6 cells

Target

Vero E6 cells

Source & Reference

NA
DBAASP
Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors. | Antiviral Res | 2009